Skip to content
healthcare.dev
Get a free key

MONJUVI

NDC 50881-013, Tafasitamab-cxix, injection, powder, lyophilized, for solution, from Incyte Corporation.

Product NDC
50881-013
Status
Listed
Labeler
Incyte Corporation
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA761163
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/50881-013 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TAFASITAMAB200 mg/5mL
Package NDCNDC-11Package
50881-013-03508810013031 VIAL in 1 CARTON (50881-013-03) / 5 mL in 1 VIAL

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/9e0a220b-517f-4c86-b581-ffbab493fb58

  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=50881-013

Use it

Look up 50881-013 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/50881-013 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 50881-013. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.